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Background: Concern has been expressed over UK epilepsy service standards but the most clinically effective model of
care is unknown.
Objective: To systematically review the current evidence on specialist epilepsy clinics compared to general neurology clinics
and specialist epilepsy nurses compared to usual care.
Methods: Medline, Psychlit, Embase, Healthplan, GEARS, BIDS ISI, UKCHHO, international HTA websites, InterTASC
databases and The Cochrane Library were searched to September 1999. Any studies comparing specialist epilepsy clinics
or nurses to generalist services or usual care, reporting physical health, costs or generic quality-of-life outcomes were included.
Two people independently applied inclusion and exclusion criteria and extracted data independently. Randomized controlled
trial (RCT) quality was assessed by Jadad score and other studies qualitatively by the likelihood of bias.
Results: Findings were one RCT and two other studies on epilepsy clinics and four RCTs and a controlled trial on epilepsy
nurses. Data synthesis was inappropriate. Epilepsy clinics showed no evidence of reduced seizure frequency or severity, no
quality-of-life information and were more expensive. Epilepsy nurse services showed no evidence of reduced seizure frequency
or severity, no effect on quality-of-life but were less expensive.
Conclusion: There is insufficient evidence to demonstrate the superiority of any particular care model for producing better
health outcomes.
c© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved
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INTRODUCTION
Epilepsy is a disorder of the nervous system involv-
ing recurrent brief disturbances of brain function.
Epilepsy is the second most common neurological
condition, with a 2–5% lifetime population preva-
lence1, 2. It can have severe psychological conse-
quences. Individuals become constrained by their
own or their carers’ fears resulting in overprotection
and unnecessary restriction of activities. There are
increased rates of depression, anxiety and poor self-
esteem3, 4. Suicide is more common than would be
expected by chance5. Seizure-related injuries range
from minor cuts and bruises to major events such
as car accidents, head injuries and serious burns6.
There is also a higher level of unemployment and
underemployment3.
Medical management of epilepsy involves hospital
specialists and GPs. In England and Wales, with a
total population of over 52 million people7, there will
be approximately 188 000 people with epilepsy and
430 000 consultations per year8.
The most appropriate model of outpatient and
general practice care is unknown but recent local audit
reports and patient satisfaction questionnaires have
expressed great concern over the current standard of
UK epilepsy services9–17. The main problems include:
• a lack of systematic follow-up,
• investigations not always appropriate,
• patients often seen in hospitals by non-
neurologists,
• inappropriate polypharmacy,
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• patients not complying with medication,
• low levels of patient knowledge.
The National Association of Health Authorities and
Trusts suggested that the morbidity and premature
mortality that result from having epilepsy could
be reduced by improving the use of specialist
skills; management of the primary/secondary care
interface; proactive monitoring and education and
self-development of staff2. Organizations such as
The Epilepsy Task Force and The Clinical Standards
Advisory Group (CSAG) have produced possible
service specifications for epilepsy18, 19. The UK
Government Department of Health response to the
CSAG reports includes a commitment (through the
National Institute for Clinical Excellence) to provide
clear guidance on the clinical and cost effective-
ness of health interventions20. Although the reports
mentioned above show that patients usually show a
preference for specialist services, they relied on expert
opinion and surveys of patients and clinicians. This
raises the question of whether there is evidence that
specialist epilepsy service provision improves patient
outcome and, if so, which is the best model of care?
OBJECTIVE
To systematically review two aspects of specialist
epilepsy care provision:
1. The evidence on the relative effectiveness and
cost-effectiveness of specialist epilepsy clinics
compared to general neurology outpatient
clinics.
2. The evidence on the relative effectiveness and
cost-effectiveness of specialist epilepsy nurses
in inpatient, outpatient or GP care compared to
‘usual care’ without a specialist epilepsy nurse.
METHODS
A protocol was developed after a scoping review
of the literature. Databases searched were Medline,
Psychlit, Embase, Healthplan, GEARS, UK Clearing
House on Healthcare Outcomes, BIDS ISI, interna-
tional HTA websites, InterTASC databases and The
Cochrane Library, up to September 1999. Search
terms included both MESH headings (e.g. epilepsy,
program evaluation, health care delivery, outpatient
clinics) and keywords (e.g. epilep*, special*, nurs*,
centr*, center*). All references in relevant published
material were reviewed. The names of epilepsy
experts were found using the World Wide Web, the
National Research Register, conference proceedings,
the Cochrane Collaboration’s e-mail conference on
Effective Professional Practice and mailing list of its
Review Group on Epilepsy. Many experts on epilepsy
(over 100) were contacted, to identify published or un-
published studies. There was no language restriction.
The inclusion criteria were any study design
comparing specialist epilepsy clinics or specialist
epilepsy nurses to generalist service provision or
usual care, which included any objectively measured
physical health outcomes, costs or generic quality
of life outcomes. Studies were excluded if they did
not distinguish between patients attending specialist
or generalist health clinics or if they reported results
of patient satisfaction surveys only. Studies reporting
expert opinion only were also excluded.
Two reviewers independently selected papers for
inclusion and extracted all relevant data. A third
reviewer was available to resolve any disagreements.
For randomized controlled trial (RCTs), quality was
assessed using the Jadad score21. The quality of other
study types was assessed for each study and each
outcome within the study on whether the methods
used were clearly stated, whether the results reported
matched the conclusions and the likelihood of bias.
Authors were contacted if there was missing or
inconsistent data, to supply further information.
Number of studies identified
To maximize the sensitivity of the search, a broad
search strategy was needed because of the large variety
of ways relevant studies might have been reported.
This produced 3887 studies. When the titles were
screened to exclude obviously irrelevant articles, 1662
studies were excluded. The abstracts were then read of
the 2225 remaining articles and a further 2074 studies
were excluded. One hundred and fifty-one potentially
relevant articles were obtained. Nineteen matched the
inclusion and exclusion criteria for the systematic
review. Eleven of these were duplicate trial reports
leaving eight RCTs or other studies to be included
in the evidence of effectiveness. Most of the 132
excluded articles were editorials, reports, background
articles and studies on specialist epilepsy services
and did not compare specialist to generalist provi-
sion. These included three cost studies22–24, three
audits on specialist epilepsy clinic provision14, 25, 26
and four audits on specialist epilepsy nurses27–30.
There were three RCTs, excluded because they
were about antiepileptic drug (AED) treatments31,
AED discontinuation regimes32 or AED compliance
strategies33. There was also one audit of epilepsy
services compared to general neurology clinics but this
contained no patient outcomes34.
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Studies found—specialist epilepsy clinics
One RCT35, 36 carried out in the UK, one matched
study37 and an audit38 from The Netherlands were
found.
In the RCT, 232 patients out of 296 cases referred
to the University Hospital in Wales, were randomized
to a specialist epilepsy clinic or a general neurology
clinic and followed up for 1 year. All patients with
epilepsy or possible epilepsy (i.e. blackouts) referred
during the study period were eligible, including
children. There were 130 allocated to the epilepsy
clinic and 102 to the neurology clinic. Follow-up
was for 3, 6 and 12 months and was carried out
on 176 patients (160 for questionnaire assessments)
who had had a seizure during the 12 month follow-
up. Outcome measures included seizure frequency,
number of seizures, seizure severity score and mean
number of AEDs. Seizure frequency was defined
as a greater than 50% reduction in the number of
seizures during the follow-up period compared to
baseline. The seizure severity score was based on the
Cramer severity score, which includes the number of
seizures during follow-up and takes into account aura,
precipitating factors and modifying factors. There
were several concerns with internal and external
validity of the RCT. There are no details as to the
number of patients actually followed up in each group.
A large number of patients were not randomized
(60 patients out of a group of 292) and they differed
significantly from the randomized group. The author
was contacted about these issues but no satisfactory
explanation was given. Assessments of outcomes were
not blinded, which made their interpretation open to
bias. This RCT was given a Jadad score of 2.
The RCT36 included a financial costing on epilepsy
and neurology outpatient clinics. A record was kept of
the number and type of staff normally in the clinics
and the number of patients seen by them in a 3-
month period. Using the RCT patients, the number
of visits by each patient and the number and type
of investigations made were then calculated. No date
or source was given on staff and investigation cost
estimates but presumably they were from local sources
shortly before 1993.
In the matched study37, 32 adults patients attending
the university hospital neurology outpatient clinic
were matched by seizure type and duration of
epilepsy (but not to severity of epilepsy) to the same
number attending a specialist epilepsy clinic. This
study was well planned but the numbers were small
and it was not blinded. The audit38 compared 225
outpatients attending the specialist epilepsy centre to
120 attending the university hospital clinic. In both
studies, all patients attending the clinics who had an
accurate history including neurophysiological data for
a firm diagnosis and suffering from well defined types
of seizures were included. Patients were excluded
from the comparisons if they had progressive brain
disorders, obvious non-compliance in drug usage or
seizure registration, pseudoseizures or severe mental
retardation. Both studies used outcome measures of
seizure remission, composite index of impairments
and mean number of AEDs. The composite index
of impairments is the sum of the seizure activity
index and the toxicity rating. The seizure activity
index includes the number of seizures during follow-
up and takes into account aura, precipitating factors
and modifying factors. The toxicity rating incorporates
neurotoxicity (symptoms such as diplopia, ataxia and
sedation, scored from 0—absent to 50—severe) and
systemic toxicity (symptoms such as hypersensitivity,
impotence or kidney dysfunction).
Numerous other studies found examined the quality
of life of people with epilepsy. However, they did
not differentiate between groups of patients attending
specialist epilepsy clinics or neurology outpatient
clinics so were not relevant to this review.
Studies found—specialist epilepsy nurses
Five studies were identified—four RCTs and a
controlled study. One RCT (Ridsdale et al. (1))39–45
and the controlled study (Mills)46–48 were based in
primary care in the UK and two in hospital outpatient
departments (Ridsdale et al. (2) and Warren)49, 50. The
fourth RCT was carried out in a US public hospital
(Schull)51. In Ridsdale et al. (1) most patients had
chronic epilepsy, whereas Ridsdale et al. (2) only
considered newly diagnosed patients, and those with
learning disabilities were excluded from both studies.
In Schull et al. there are no details as to whether
patients were newly diagnosed or not. Warren and
Mills et al. included both new and follow-up patients
and people with learning disabilities. In the Warren
trial, people with learning disabilities comprised
less than 10% of those recruited. The interventions
all considered specialist epilepsy nurses, but it is
not known from any of the trials what specialist
training the nurses had received before they counselled
patients, whether they had similar qualifications and
how similar their interventions were. One could
conclude that it is possible that personal factors about
the nurse may have influenced patient outcomes and
hence the final results.
Details of the trial designs are shown in Table 1.
Although all of the trials were primarily investigating
the process of care, they all included some physical
health or generic quality of life outcomes.
In Ridsdale et al. (1)39–42 a questionnaire had
to be completed by each person before inclusion
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Table 1: Epilepsy nurse trial details.
Ridsdale (1) Ridsdale (2) Schull Warren Mills
Patient
definition
Aged over 15.
Established diagnosis
of epilepsy. Seizure
within last 2 years or
taking AEDs
Aged over 17.
New diagnosis of
epilepsy. Two or more
seizures at initial
treatment with AEDs.
Returned initial
questionnaire
Epilepsy-related
diagnoses (new onset,
uncontrolled or
seizures related to
intracranial lesions,
drug toxicity or
overdose)
Aged 16 or over.
Diagnosis of epilepsy or
possible epilepsy
confirmed within 6-month
follow-up period.
Attending outpatient
service (new or follow up)
Aged 16 or over.
Currently on AEDs
for epilepsy
Exclusions Other severe illness,
e.g. cancer, active
psychosis or severe
depression. Low IQ
from learning
disability or
dementia. Failure to
return initial
questionnaire
Learning or language
difficulties making it
impossible to
complete a
questionnaire. Severe
medical or
psychological disease
Surgical procedures
for evaluation or
treatment of
uncontrolled seizures
No epilepsy diagnosed
during the 6-month
follow-up. Refusing, not
attending or cancelling
appointments. In another
RCT or previous nurse
specialist contact.
Receiving a different
treatment to that allocated.
Lack of waiting room
time, administrative error
or clinic cancelled
appointment
None
Method of
randomiza-
tion
Not stated In blocks. Method not
stated
Not stated Computer generated block
randomization with sealed
envelope
N/A
Power
calculation
No Yes No No Yes
Method of
data
collection
Questionnaire survey
(HADS and
knowledge)
Questionnaire survey
(advice provided,
knowledge, HADS)
Hospital
computerized
information system
and patient records
Postal questionnaire and
data extraction from
medical records (HADS,
Impact of Epilepsy Scale)
Questionnaire
completed by patient
or carer
Blinding of
outcome
assessment
No Not stated Not stated No Not stated
Jadad score 2 2 1 3 N/A
Outcome
measures
Depression, AED
blood levels,
knowledge of
epilepsy, whether
advice given
Depression, anxiety,
knowledge of
epilepsy, whether
advice given, patient
satisfaction
Length of stay.
Seizure related
readmissions at 30
and 90 days,
emergency
department and
ambulatory clinic
visits, appointment
compliance
Seizure frequency, AED
side effects, injuries from
seizures, epilepsy related
service use, HADS,
Impact of Epilepsy Scale,
absence from work,
knowledge of epilepsy,
treatment compliance,
clinic attendance,
satisfaction with GP,
outpatient clinic and nurse
specialist, EUROQOL
health status
Primary
outcomes—frequency
of seizures, use of
AEDs, provision of
information, use of
care, attitudes to care.
Secondary
outcomes—
preference of 1◦ or 2◦
based care, perceived
effect of epilepsy and
its treatment on
everyday life
Treatment Primary care Secondary care Tertiary care Secondary care Primary care
Nature of
intervention
Nurse run clinic
(? definition)
Specialist epilepsy
nurse run clinic
Epilepsy nurse
specialist case
manager
Epilepsy nurse specialist
case manager
Nurse run clinic plus
liaison between and
education of local
health service
Follow-up 6 months 6 months 90 days 6 months 1 year, 2 years
Intention to
treat analysis
Yes ?Yes Probably yes No Yes
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into the study. Therefore the participants were a
self-selected, probably more compliant group than
those who did not fill out the questionnaire. The
non-responders may also have been less affected
by epilepsy. Alternatively, the attraction of a spe-
cialist nurse service may have encouraged people
more affected by epilepsy to take part. There
was no comparison made between responders and
non-responders and the study was not blinded to
allocation of intervention or outcome assessment.
Ridsdale et al. (2)49 had a similar recruitment design.
Comparison between responders and non-responders
showed that the non-responders were significantly
younger. As both trials were based on respondents
to questionnaires, it is probable that the results
are only generalizable to more compliant patients
with epilepsy. The outcome measures used on both
trials included seizure frequency and depression. Self
report seizure frequency was presented as numbers
seizure-free for the previous 6 months39–42 (or time
in months since last seizure49). Depression was
measured using the Hospital Anxiety and Depression
Scale. A cut off score of eight was used to define
people with depression.
With Schull et al.51 there are only very sketchy
details available, very few outcomes reported and
no outcome definitions. It is impossible to know
how well the trial was carried out and the small
sample sizes meant that statistically significant results
were very unlikely.
In Warren50 all patients not attending, cancelling
or refusing appointments were excluded from the
study. Patients were also excluded if they received
a different intervention from that to which they
had been randomly allocated. Patients who dropped
out of the study were not followed up. Therefore
the study results may only be generalizable to
compliant patients over 16 who happen to not have
had their clinic appointments cancelled or been
subject to administrative error. The main physical
outcomes reported included seizure frequency during
the 6 months of the trial follow-up, AED side effects
and depression. The AED side effects were measures
by a self-report scale of 19 side effect items with a four
point Likert scale response. Higher scores indicated
more side effects and the list included common
neurological, systemic and psychological AED side
effects. Depression was measured using the Hospital
Anxiety and Depression Scale.
In the Mills et al. trial46–48, 14 similar GP practices
were involved in the study and the specialist epilepsy
nurse worked with staff and all patients with epilepsy
in seven of these practices. The study was not
randomized and there was no description of the
method of allocation of GP practices to epilepsy
nurse or not. The questionnaire survey had a response
rate of only 40.3% of all eligible adults at 2 years
(non-responders were followed up three times). The
response rate was very similar between intervention
and control groups. Therefore the results may only
be generalizable to more compliant GP patients. The
outcome measures included seizure frequency and
AED side effects. Seizure frequency was recorded
by self-report as having had one or more seizures
within the previous year.
The Warren RCT50 carried out the only economic
analysis found. A financial costing was made on
the primary and secondary NHS service use and
costs using data from the local NHS Trust finance
department and annually published national data. This
calculated the number and type of staff used in
both primary and secondary care, inpatient admissions
and investigations performed for most of the trial
participants over the 6 months that the RCT took place.
All costs pertained to 1996/97. It also carried out the
only generic quality of life study found. Patients from
intervention and control groups were assessed at the
6-month follow-up using the EUROQOL weighted
health status and self-rated health measures.
All other outcomes recorded in the five trials relate
to the process of care and the feelings of the patient.
RESULTS—SPECIALIST EPILEPSY CLINICS
The RCT35, 36 physical outcome results showed that
in the specialist epilepsy clinic group there were
significant improvements in seizure frequency at 3 and
6 months but not at 12 months (as measured by a
greater than 50% reduction in seizure frequency over
baseline). Also the self-reported seizure severity score
was significantly improved in the epilepsy clinic group
compared to the neurology clinic group at 3 months
but not thereafter (see Table 2).
The RCT cost estimates gave a total mean clinic
cost per patient per year of £106.57 for the epilepsy
clinic and £91.91 for the neurology clinic. Only point
estimates of costs were given, without any distribution
information, so it is impossible to calculate the sta-
tistical significance of the difference between the two
costs. Some of the costs were calculated on all clinic
patients (staff costs per outpatient visit) and some
just on the RCT patients (total cost of investigations)
which meant that there was a presumption that all
clinic patients were similar. However, as randomized
and non-randomized patients differed, it is unclear
how this would have affected the results.
The matched study37 showed that complete seizure
remission was achieved for significantly more patients
at the neurology clinic than the epilepsy clinic but
there were no significant differences in seizure activity
index. Significantly more patients at the neurology
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Table 2: Results of epilepsy vs neurology outpatient clinics.
Study type RCT Matched Audit
First author Morrow J. I. Lammers M. W. Wijsman D. J.
Seizure frequency Specialist 54%b — —
(>50% reduction from baseline) Generalist 42%b — —
Complete seizure remissiona Specialist 54%b 18.8%∗ 19.2%∗
Generalist 44%b 56.3%∗ 43.3%∗
Mean seizure severity score Specialist 30b — —
Generalist 38b — —
Composite index of Specialist — 9.4% 10.7%
impairments > 100 Generalist — 18.8% 10.8%
Mean number of AEDs Specialist 1 1.8 2.0
Generalist 1 1.4 1.4
aComplete remission for 3 months in those followed up; bEstimated from graph; ∗ p < 0.05.
clinic had a composite index of impairments of
zero, indicating that they were seizure free and had
no side effects of medication (see Table 2). The
audit38 showed that the specialist epilepsy centre
patients had a wider diversity of seizure types and
a greater diversity of drugs were prescribed. The
mean seizure activity index was significantly higher
at the epilepsy centre than the neurology clinic.
There were very important differences in baseline
characteristics and outcomes of treatment between
patients attending the two clinics, clearly showing
that there is normally a selection bias operating and
because of their study designs, neither study could
show whether epilepsy clinics are more effective than
neurology outpatient clinics.
RESULTS—SPECIALIST EPILEPSY NURSES
Ridsdale et al. (1)39–42 showed no significant differ-
ence in rates of being seizure-free for the previous
6 months or the number of people depressed in the
two groups. They report that the median depression
score was significantly lower in the intervention
group compared to controls but no scores were
presented. In a sub-group analysis of number of
people with depression compared to presence or
absence of seizures within the previous 6 months,
the difference was only seen in the no recent seizure
group (relative risk 3.15, 95% confidence interval
1.15–8.60). Ridsdale et al. (2)49 showed no significant
differences in time since last seizure or depression
between the two groups. Schull et al.51 showed no
difference in mean length of inpatient stay between
case managed and non-case managed groups (6.97
vs. 6.79 days), no seizure related admissions at
30 days for either group but an increase in seizure-
related readmissions at 90 days in the non-case
managed group. No significance tests were given.
Warren50 failed to find a significant improvement
in any medical or psychological outcomes for the
specialist epilepsy nurse group compared to the
hospital outpatient clinic group. Mills et al.47, 48 at
both 1 year and 2 year follow-up found no significant
improvements in medical or psychological outcomes
for the specialist epilepsy nurse group compared to
care by GPs. A summary of the results is shown in
Table 3.
In the Warren RCT50, the total mean NHS cost per
patient per year was £674 for the epilepsy nurse group
and £858 for usual care. This was not a statistically
significant reduction and was largely accounted for by
the lower cost for an epilepsy nurses’ time compared
to that for a doctor. The EUROQOL quality of
life results showed that there were no significant
differences between the two groups on both weighted
health status and self-rated health.
DISCUSSION
With specialist epilepsy clinics the information
available was sparse and of poor quality. The single
RCT available was poorly designed and conducted
and patients who withdrew had much more severe
epilepsy with more frequent seizures than those
who remained within the RCT. Many more people
withdrew from the neurology clinic arm of the trial,
so, even though seizure frequency was not given at
baseline, the two groups were almost certainly not
comparable. Therefore the results cannot be taken
as proof that epilepsy clinics are more effective
than neurology outpatient clinics. Although providing
interesting information, the other studies reviewed
cannot provide evidence of increased effectiveness
of epilepsy clinics because the case-mix of patients
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Table 3: Epilepsy nurse results.
Ridsdale (1) Ridsdale (2) Schull Warren Mills
Seizure frequency OR = 1.02
Time since last seizure (months) Specialist 6.5/47
Usual care 4.9/43
Seizure-free for previous 6 months Specialist 67.4%/92 30%/80
Usual care 67.7%/96 27%/111
Seizure related readmission Specialist 0
(90 days) Usual care 3
AED side effects Specialist 65%/81 OR = 1.69
Usual care 71%/112
Depression Specialist 15.2%/92 19%/47 18%/85
Usual care 19.8%/96 19%/43 15%/117
∗ p < 0.05; OR = Odds ratio of epilepsy nurse compared to ‘usual care’; /n = number followed up.
attending neurology outpatient clinics was different
from those attending epilepsy clinics.
Although more research evidence was available
on the effectiveness of specialist epilepsy nurses,
none of the RCTs, nor the controlled study, showed
any differences between the two groups regarding
seizure frequency or seizure severity. There was some
evidence that incidence of depression was decreased
in the epilepsy nurse group in one study but not in the
other two. There was good evidence that the process
of care and/or patient satisfaction was improved in
the epilepsy nurse groups compared to control but
improved clinical outcomes were not demonstrated.
The one RCT that compared quality of life outcomes
showed no difference between the epilepsy nurse and
usual care groups at 6 months follow-up.
Thus there is no convincing evidence, from the
RCTs or other studies reviewed, that specialist
epilepsy clinics improve patient outcomes when
compared to general outpatient neurology clinics
or that specialist epilepsy nurses improve patient
outcomes when compared to usual care in an inpatient,
outpatient or GP setting. However, given the poor
quality of information available, the failure to find
an effect could well be due to the lack of adequate
research rather than because there is no effect of
specialist treatment on outcomes.
CONCLUSIONS
Although it is generally acknowledged that the
present quality of care for people with epilepsy could
be considerably improved, we found little reliable
empirical evidence to show that one model of care
was superior to any other. The evidence on costs
suggests that epilepsy clinics are very slightly more
expensive than neurology outpatient clinics while
specialist epilepsy nurses work out slightly cheaper
because nurse consultation costs are cheaper than
doctor consultation costs.
More research is needed to determine the most
clinically effective model of service provision for
people with epilepsy which would provide ‘the best
standard’ of health care. In view of the lack of
evidence about models of care for epilepsy services,
the authors are currently undertaking a further
systematic review of studies comparing specialist to
generalist clinics and specialist nurses to usual care
for other chronic medical conditions to see whether
anything can be learnt about the relative effectiveness
of different models of care that could give some
guidance on how to organize epilepsy services.
However, it is generally conceded that improvements
in care for people with epilepsy are required now—
changes should not be postponed awaiting conclusive
evidence that may not materialize. The lower cost and
the fact that patient satisfaction and the process of care
was superior with specialist epilepsy nurses suggests
that, in the absence of evidence showing that superior
outcomes are achieved with a particular model of care,
this could be an appropriate method of delivering
care in the interim.
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